
BioLife Solutions BLFS
€ 18.58
1.96%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBAL |
Anteile |
46.1 M |
Marktkapitalisierung |
$ 1 B |
EBITDA (LTM) |
$ -17.1 M |
P/E (LTM) |
-57.78 |
P/S (LTM) |
9.97 |
EPS (LTM) |
-0.37 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 127.48 | 4.19 % | $ 4.08 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.05 | 2.27 % | $ 187 M | Nasdaq Capital Market | ||
|
Microbot Medical
MBOT
|
$ 2.18 | -0.91 % | $ 99.8 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.32 | - | $ 26.3 M | NYSE American | ||
|
Envista Holdings Corporation
NVST
|
$ 27.04 | 0.9 % | $ 4.54 B | NYSE | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 76.34 | 0.73 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 11.26 | 0.72 % | $ 27.3 M | Nasdaq Capital Market | ||
|
STERIS plc
STE
|
$ 222.0 | 0.09 % | $ 21.9 B | NYSE,SPB | ||
|
The Cooper Companies
COO
|
$ 64.91 | 0.76 % | $ 12.9 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Teleflex Incorporated
TFX
|
$ 136.61 | 0.04 % | $ 6.1 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Utah Medical Products
UTMD
|
$ 67.71 | 0.8 % | $ 219 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 60.24 | 0.52 % | $ 3.03 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.37 | 3.11 % | $ 54 K | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 123.66 | -0.93 % | $ 3.05 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 481.38 | -0.18 % | $ 172 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 306.32 | 0.14 % | $ 22.1 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 123.44 | 1.61 % | $ 5.98 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.66 | 0.02 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.83 | 4.74 % | $ 224 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 68.08 | -0.73 % | $ 4.03 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 22.88 | -0.61 % | $ 1.54 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.04 | 1.05 % | $ 2.4 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.62 | -4.3 % | $ 18.6 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 52.01 | -0.17 % | $ 171 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.43 | 0.86 % | $ 2.59 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
STAAR Surgical Company
STAA
|
$ 26.37 | 2.73 % | $ 1.31 B | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.93 | - | $ 176 M | NYSE American | ||
|
Baxter International
BAX
|
$ 18.36 | 1.16 % | $ 9.42 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 220.37 | 0.24 % | $ 32.2 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.33 | 0.17 % | $ 1.4 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.72 | -2.04 % | $ 298 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.24 | 1.26 % | $ 459 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 152.46 | 0.21 % | $ 43.9 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.03 | 5.4 % | $ 31.5 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.03 | 0.83 % | $ 223 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 118.26 | 0.56 % | $ 6.59 M | Nasdaq Global Select Market,SPB |